Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ana‐Maria Bucalau"'
Autor:
Benoît Collette, Marie Mannie-Corbisier, Ana-Maria Bucalau, Nicolas Pauly, Gontran Verset, Rodrigo Moreno-Reyes, Patrick Flamen, Nicola Trotta
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-17 (2024)
Abstract Background Developments in transarterial radioembolization led to the conception of new microspheres loaded with holmium-166 (166Ho). However, due to the complexity of the scatter components in 166Ho single photon emission computed tomograph
Externí odkaz:
https://doaj.org/article/1c918510c5b244db802f3fa66d328162
Autor:
Ana-Maria Bucalau, Benoît Collette, Illario Tancredi, Michael Vouche, Martina Pezzullo, Jason Bouziotis, Rodrigo Moreno-Reyes, Nicola Trotta, Hugo Levillain, Jean Luc Van Laethem, Gontran Verset
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-18 (2023)
Abstract Background Recent data demonstrated that personalized dosimetry-based selective internal radiotherapy (SIRT) is associated with better outcome for unresectable hepatocellular carcinoma (HCC). Aim We aim to evaluate the contribution of person
Externí odkaz:
https://doaj.org/article/1a41195234d7455784eb58c9be7da477
Autor:
Ana-Maria Bucalau, Illario Tancredi, Martina Pezzullo, Raphael Leveque, Simona Picchia, Jean-Luc Van Laethem, Gontran Verset
Publikováno v:
Hepatic Oncology, Vol 8, Iss 1 (2021)
Aim: Evaluation of safety and efficacy of selective balloon-occluded transarterial chemoembolization using polyethylene glycol embolizing microspheres in patients with hepatocellular carcinoma. Materials & methods: Twenty-four consecutive patients we
Externí odkaz:
https://doaj.org/article/cc5e2422b1e046df9d3480f3e97b5869
Autor:
Nicola Trotta, Benoît Collette, Céline Mathey, Irina Vierasu, Ana‐Maria Bucalau, Gontran Verset, Rodrigo Moreno‐Reyes, Serge Goldman
Publikováno v:
Medical Physics. 49:7567-7582
Publikováno v:
Current Opinion in Oncology. 34:403-411
To summarize targeted therapies and immunotherapy as treatment for advanced/metastatic biliary tract cancers and discuss ongoing clinical trials.For the first time since gemcitabine-cisplatin was set as the standard of care in first-line advanced/met
Publikováno v:
Cureus.
Autor:
Nika De Wilde, Luisa Vonghia, Sven Francque, Thomas De Somer, Ali Bagdadi, Eva Staub, Jasper Lambrechts, Ana-Maria Bucalau, Gontran Verset, Christophe Van Steenkiste
Publikováno v:
World journal of hepatology
BACKGROUNDHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. The landscape of the systemic treatment for advanced HCC is changing quickly, and recently, the standard of care became either atezolizumab plus